Compare Baker Hughes Co (BKR) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baker Hughes Co vs Ginkgo Bioworks Holdings Inc — how do they compare? Baker Hughes Co trades at $64.83 (market cap $63.60B), while Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $515.15M). The key difference: Baker Hughes Co is far larger — about 123.5× Ginkgo Bioworks Holdings Inc's market cap, and Baker Hughes Co pays a 1.44% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| BKR | DNA | |
|---|---|---|
Market Cap | $63.60B | $515.15M |
Sector | Energy | Health |
52-Week High | $69.67 | $16.14 |
52-Week Low | $42.51 | $5.48 |
Enterprise Value | $64.13B | $617.10M |
Dividend Yield | 1.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Ginkgo Bioworks (DNA) trades at $7.97, down 6.24% today, reflecting ongoing operational challenges. The company reported Q2 2026 revenue of $20 million, a 48% year-over-year decline, as it shifts focus to autonomous lab systems. Despite beating EPS expectations in two of the last three quarters, net losses remain substantial with a -219.6% margin. Technical indicators show bearish momentum with support at $7 and resistance at $9.
DNA faces significant headwinds with declining revenue and persistent losses, though analyst sentiment is mixed with 45% buy ratings. The pivot to new business lines creates uncertainty, while cash burn and competitive pressures present substantial risks. Upside depends on successful execution of the strategic shift and path to profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Baker Hughes Co
Baker Hughes is a global leader in oilfield services and oilfield equipment, with particularly strong presences in the artificial lift, specialty chemicals, and completions markets. The other half of its business focuses on industrial power generation, process solutions, and industrial asset management, with high exposure to the liquid natural gas market specifically, as well as broader industrials end markets.
Read more on BKR →About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →
